Shanghai OB/GYN Hospital, Fudan University, Shanghai, China.
Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Fudan University, Shanghai, China.
J Clin Endocrinol Metab. 2020 Nov 1;105(11). doi: 10.1210/clinem/dgaa550.
While fibrosis in endometriosis has recently loomed prominently, the sources of myofibroblasts, the principal effector cell in fibrotic diseases, remain largely obscure. Mesothelial cells (MCs) can be converted into myofibroblasts through mesothelial-mesenchymal transition (MMT) in many fibrotic diseases and adhesion.
To evaluate whether MCs contribute to the progression and fibrogenesis in endometriosis through MMT.
SETTING, DESIGN, PATIENTS, INTERVENTION, AND MAIN OUTCOME MEASURES: Dual immunofluorescence staining and immunohistochemistry using antibodies against calretinin, Wilms' tumor-1 (WT-1), and α-smooth muscle actin (α-SMA) were performed on lesion samples from 30 patients each with ovarian endometrioma (OE) and deep endometriosis (DE), and 30 normal endometrial (NE) tissue samples. Human pleural and peritoneal MCs were co-cultured with activated platelets or control medium with and without neutralization of transforming growth factor β1 (TGF-β1) and/or platelet-derived growth factor receptor (PDGFR) and their morphology, proliferation, and expression levels of genes and proteins known to be involved in MMT were evaluated, along with their migratory and invasive propensity, contractility, and collagen production.
The number of calretinin/WT-1 and α-SMA dual-positive fibroblasts in OE/DE lesions was significantly higher than NE samples. The extent of lesional fibrosis correlated positively with the lesional α-SMA staining levels. Human MCs co-cultured with activated platelets acquire a morphology suggestive of MMT, concomitant with increased proliferation, loss of calretinin expression, and marked increase in expression of mesenchymal markers. These changes coincided with functional differentiation as reflected by increased migratory and invasive capacity, contractility, and collagen production. Neutralization of TGF-β1 and PDGFR signaling abolished platelet-induced MMT in MCs.
MCs contribute to lesional progression and fibrosis through platelet-induced MMT.
虽然子宫内膜异位症中的纤维化最近备受关注,但纤维化疾病的主要效应细胞——肌成纤维细胞的来源在很大程度上仍不清楚。在许多纤维化疾病和黏附中,间皮细胞(MCs)可以通过间皮-间充质转化(MMT)转化为肌成纤维细胞。
评估 MCs 是否通过 MMT 促进子宫内膜异位症的进展和纤维化。
设置、设计、患者、干预措施和主要观察指标:对 30 例卵巢子宫内膜异位囊肿(OE)和深部子宫内膜异位症(DE)患者的病变样本和 30 例正常子宫内膜(NE)组织样本进行双重免疫荧光染色和免疫组织化学染色,使用 calretinin、Wilms 肿瘤-1(WT-1)和α-平滑肌肌动蛋白(α-SMA)抗体。将人胸膜和腹膜 MCs 与激活的血小板或对照培养基共培养,并在 TGF-β1 和/或血小板衍生生长因子受体(PDGFR)中和及其形态、增殖以及已知参与 MMT 的基因和蛋白的表达水平进行评估,以及它们的迁移和侵袭倾向、收缩性和胶原蛋白产生。
OE/DE 病变中 calretinin/WT-1 和 α-SMA 双重阳性纤维母细胞的数量明显高于 NE 样本。病变纤维化程度与病变 α-SMA 染色水平呈正相关。与激活的血小板共培养的人 MC 获得了提示 MMT 的形态,同时增殖增加,calretinin 表达丧失,间充质标志物表达显著增加。这些变化与功能分化一致,表现为迁移和侵袭能力、收缩性和胶原蛋白产生增加。中和 TGF-β1 和 PDGFR 信号可消除血小板诱导的 MC 中的 MMT。
MCs 通过血小板诱导的 MMT 促进病变进展和纤维化。